Phil Patten
Chief Scientific Officer at Initial Therapeutics | San Francisco Bay Area
Engage
candidates 10x faster
Enjoy unlimited access and discover candidates outside of LinkedIn
Trusted by 1.4M users from 76% of Fortune 500 companies
The most accurate data ever
CCPA Compliant
GDPR Compliant
150M
Personal Emails
200M
Work Emails
100M
Direct Dials
250M
Professional Profiles
40M
Company Profiles
Find anyone, anywhere
with ContactOut
today
Making remote or global hires?
Connecting
with key decision-makers? We can help.
- 40 emails / month
- 3 phone numbers / month
- Works on standard LinkedIn only
-
Work emails, personal emails,
mobile numbers
No credit card required
Chief Scientific Officer at Initial Therapeutics in October 2020 to Present
Entrepreneur in Residence and CSO Initial Therapeutics at Apple Tree Partners in October 2020 to December 2021
Founder, Chief Scientific Officer at DiCE Molecules in January 2014 to January 2020
Director, Trait Engineering Technology & DuPont Fellow at Pioneer Hi-Bred in January 2010 to January 2014
Senior Vice President, Biology at Achaogen in January 2004 to June 2010
Vice President, Technology at Maxygen in January 1996 to January 2004
See more
See less
Stanford University, Doctor of Philosophy - PhD
Caltech, Bachelor of Science - BS
See more
See less
Assay Development
Life Sciences
Biotechnology
Biopharmaceuticals
Immunology
Molecular Biology
Bioinformatics
Start-ups
Entrepreneurship
Intellectual Property
Venture Capital
Clinical Development
Cell Biology
Oncology
Clinical Trials
Genomics
Project Portfolio Management
Business Development
Commercialization
CRO Management
Performance Improvement
People Management
R&D Operations
Directed Evolution
R&D Funding
Synthetic Biology
Biological Engineering
IPO
Biologics
Strategic Alliances
Angel Investing
Board of Directors
Federal Grants Management
Antibodies
Crispr
Gene Editing
Small Molecules
Agricultural Chemicals
Out-licensing
Intellectual Property Law
Patent Portfolio Management
Gene Synthesis
Key Opinion Leaders
Natural Products
New Drug Application (NDA)
DNA Sequencing
RNAseq
Investigational New Drug Application IND
Drug Discovery & Development
Biochemistry
See more
See less
Discover more about Initial TherapeuticsWhat is Phil Patten email address?
Email Phil Patten at [email protected] and [email protected]. This email is the most updated Phil Patten's email found in 2026.
How to contact Phil Patten?
To contact Phil Patten send an email to [email protected] or [email protected].
What company does Phil Patten work for?
Phil Patten works for Initial Therapeutics
What is Phil Patten's role at Initial Therapeutics?
Phil Patten is Chief Scientific Officer
What is Phil Patten's Phone Number?
Phil Patten's phone (**) *** *** 421
What industry does Phil Patten work in?
Phil Patten works in the Biotechnology industry.
Phil Patten Email Addresses
Phil Patten Phone Numbers
Get a free list of similar prospects, filtered by title, company, or industry.
Build your Prospect ListPeople like Phil Patten
Independent Business Consultant at Self-employed
Regional Director at Meso Scale Discovery
Quality Assurance Compliance Manager at RoosterBio Inc.
Owner / Manager at Beneduce Vineyards
Professor of Law and Barnett Chair in Trial Advocacy at University of San Francisco School of Law
Postdoctoral Researcher at Memorial Sloan Kettering Cancer Center
Director, Operations Engineering at Pattern Energy Group
Producer/Director/Editor at Smoking Monkey Media
Head Men's Basketball Coach at Crest High School
Vice President of Sales at Production Automation Corporation
Producer at Snap Inc.
Area Coach/Director of Operations at Ruby Tuesday
Security Professional at Lexington Market
Buyer at zulily
Vice President, Business Development and Partnerships at Ceros
Director, North America Digital Marketing at Converse
Sole Proprietor at Sketch Monkey Entertainment
Project Manager/Learning Facilitator at Questrom School of Business, Boston University
Actor at SAG-AFTRA
Sponsorship Director at DiningOut Magazine
Senior Product Manager at Amazon
Owner at www.zachmcgowan.com
President and Chief Executive Officer at Guarionex Press Ltd.
News Director at Tribune Broadcasting
Show more
Show less